AAAAAA

   
Results: 1-13 |
Results: 13
SAFETY AND IMMUNOGENICITY OF AN INACTIVATED SUBUNIT INFLUENZA-VIRUS VACCINE COMBINED WITH MF59 ADJUVANT EMULSION IN ELDERLY SUBJECTS, IMMUNIZED FOR 3 CONSECUTIVE INFLUENZA SEASONS
Authors: MINUTELLO M SENATORE F CECCHINELLI G BIANCHI M ANDREANI T PODDA A CROVARI P
Citation: M. Minutello et al., SAFETY AND IMMUNOGENICITY OF AN INACTIVATED SUBUNIT INFLUENZA-VIRUS VACCINE COMBINED WITH MF59 ADJUVANT EMULSION IN ELDERLY SUBJECTS, IMMUNIZED FOR 3 CONSECUTIVE INFLUENZA SEASONS, Vaccine, 17(2), 1999, pp. 99-104
INTERFERON-ALFA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C AND PERSISTENTLY NORMAL AMINOTRANSFERASE ACTIVITY
Authors: SERFATY L CHAZOUILLERES O PAWLOTSKY JM ANDREANI T PELLET C POUPON R
Citation: L. Serfaty et al., INTERFERON-ALFA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C AND PERSISTENTLY NORMAL AMINOTRANSFERASE ACTIVITY, Gastroenterology, 110(1), 1996, pp. 291-295
TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA BEFORE PREGNANCY
Authors: GRANGE JD ABERGEL A AMIOT X AYGALENCQ P ANDREANI T BOMMELAER G BODIN F
Citation: Jd. Grange et al., TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA BEFORE PREGNANCY, Gastroenterology, 108(4), 1995, pp. 1075-1075
HCV INFECTION ASSOCIATED WITH SJOGRENS-SYNDROME
Authors: WATTIAUX MJ JOUANFLAHAULT C SERFATY L ANDREANI T CABANE J IMBERT JC YOUINOU P
Citation: Mj. Wattiaux et al., HCV INFECTION ASSOCIATED WITH SJOGRENS-SYNDROME, Arthritis and rheumatism, 38(9), 1995, pp. 1344-1344
GOUGEROT-SJOGRENS-SYNDROME ASSOCIATED WIT H HEPATITIS-C - 6 CASE-REPORTS
Authors: WATTIAUX MJ JOUANFLAHAULT C YOUINOU P CABANE J ANDREANI T SERFATY L IMBERT JC
Citation: Mj. Wattiaux et al., GOUGEROT-SJOGRENS-SYNDROME ASSOCIATED WIT H HEPATITIS-C - 6 CASE-REPORTS, Annales de medecine interne, 146(4), 1995, pp. 247-250
LEVEL OF VIREMIA, GENOTYPE, HISTOLOGICAL FEATURES AND EFFECT OF INTERFERON (IFN) THERAPY IN HEPATITIS-C VIRUS (HCV) CARRIERS WITH PERSISTENTLY NORMAL ALT ACTIVITY
Authors: SERFATY L CHAZOUILLERES O PAWLOTSKY JM ANDREANI T PELLET C POUPON R
Citation: L. Serfaty et al., LEVEL OF VIREMIA, GENOTYPE, HISTOLOGICAL FEATURES AND EFFECT OF INTERFERON (IFN) THERAPY IN HEPATITIS-C VIRUS (HCV) CARRIERS WITH PERSISTENTLY NORMAL ALT ACTIVITY, Hepatology, 20(4), 1994, pp. 10000165-10000165
FACTORS PREDICTIVE OF THE RESPONSE TO INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: SERFATY L GIRAL P LORIA A ANDREANI T LEGENDRE C POUPON R
Citation: L. Serfaty et al., FACTORS PREDICTIVE OF THE RESPONSE TO INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C, Journal of hepatology, 21(1), 1994, pp. 12-17
A RANDOMIZED, CONTROLLED TRIAL OF INTERFERON ALFA-2B ALONE AND WITH SIMULTANEOUS PREDNISONE FOR THE TREATMENT OF CHRONIC HEPATITIS-B
Authors: ZARSKI JP CAUSSE X COHARD M COUGNARD J TREPO C ABERGEL A ANDREANI T AUCOUTURIER JP BAESJOU S BERNARD PA BORG R BRESSONHADNI S BUFFET C DESMORAT H DUFFAUT M KLOTZ F LEVY VG MOREAU J PETIT R CALES P POL S BERTHELOT P POYNARD T RINALDI Y TRAN A VALLA D VETTER D
Citation: Jp. Zarski et al., A RANDOMIZED, CONTROLLED TRIAL OF INTERFERON ALFA-2B ALONE AND WITH SIMULTANEOUS PREDNISONE FOR THE TREATMENT OF CHRONIC HEPATITIS-B, Journal of hepatology, 20(6), 1994, pp. 735-741
COMPARISON OF ANTI-HBE-POSITIVE AND HBE-ANTIGEN-POSITIVE CHRONIC HEPATITIS-B IN FRANCE
Authors: ZARSKI JP MARCELLIN P COHARD M LUTZ JM BOUCHE C RAIS A ANDREANI T ANTONI M BERNARD PH BUFFET C CHAMPIGNEULLE B CHAUSSADE S GRASSET D JOUANOLLE H DEGOTT C BENHAMOU JP METREAU JM ZAFRANI ES MOREAU X OUZAN D PASQUIER D HADOUR FL POL S CARNOT F POYNARD T ROUGIE P GODINOT H TREPO C CHEVALLIER M VALLA D VETTER D BACQ Y
Citation: Jp. Zarski et al., COMPARISON OF ANTI-HBE-POSITIVE AND HBE-ANTIGEN-POSITIVE CHRONIC HEPATITIS-B IN FRANCE, Journal of hepatology, 20(5), 1994, pp. 636-640
IMPACT OF SCREENING DONOR BLOOD FOR ALANINE AMINOTRANSFERASE AND ANTIBODY TO HEPATITIS-B CORE ANTIGEN ON THE RISK OF HEPATITIS-C VIRUS TRANSMISSION
Authors: JULLIEN AM COUROUCE AM MASSARI V MANIEZ M FINETTI P BREVIERE D GIRARD M ANDREANI T HABIBI B
Citation: Am. Jullien et al., IMPACT OF SCREENING DONOR BLOOD FOR ALANINE AMINOTRANSFERASE AND ANTIBODY TO HEPATITIS-B CORE ANTIGEN ON THE RISK OF HEPATITIS-C VIRUS TRANSMISSION, European journal of clinical microbiology & infectious diseases, 12(9), 1993, pp. 668-672
HYPOCHOLESTEROLEMIA IS ASSOCIATED TO CHRONIC HEPATITIS-C
Authors: GIRAL P SERFATY L ANDREANI T LORIA A PARADIS V CHAZOUILLERES O POUPON R
Citation: P. Giral et al., HYPOCHOLESTEROLEMIA IS ASSOCIATED TO CHRONIC HEPATITIS-C, Hepatology, 18(4), 1993, pp. 10000232-10000232
CHRONIC VIRAL HEPATITIS-C (CH-C) - BIOLOGICAL AND HISTOPATHOLOGICAL CORRELATIONS
Authors: LORIA A GIRAL P SERFATY L ANDREANI T GUECHOT J POUPON R
Citation: A. Loria et al., CHRONIC VIRAL HEPATITIS-C (CH-C) - BIOLOGICAL AND HISTOPATHOLOGICAL CORRELATIONS, Hepatology, 18(4), 1993, pp. 10000240-10000240
SERUM ALT ACTIVITY AFTER ONE MONTH TREATMENT IS THE BEST PREDICTIVE FACTOR OF EARLY AND LONG-TERM RESPONSE TO INTERFERON-ALPHA-2A IN CHRONIC HEPATITIS-C - A MULTIVARIATE-ANALYSIS ON 295 TREATED PATIENTS
Authors: OUZAN D SKAF R ANDREANI T OPOLON P TREPO C MICHEL P COUZIGOU P DUFFAUT M MARCELLIN P ZARSKI JP LEVY VG BERNARD P MATHIEUCHANDELIER C EUGENE C GRANGE JD GAUTHIER A VALLA A CAMATTE P POUPON R VALLA D PARIS JC OLIVARES R BABANY G
Citation: D. Ouzan et al., SERUM ALT ACTIVITY AFTER ONE MONTH TREATMENT IS THE BEST PREDICTIVE FACTOR OF EARLY AND LONG-TERM RESPONSE TO INTERFERON-ALPHA-2A IN CHRONIC HEPATITIS-C - A MULTIVARIATE-ANALYSIS ON 295 TREATED PATIENTS, Hepatology, 18(4), 1993, pp. 10000248-10000248
Risultati: 1-13 |